Literature DB >> 22622956

Glucose transporter-1 (GLUT1) deficiency syndrome: diagnosis and treatment in late childhood.

Gwendolyn Gramer1, Nicole I Wolf, Daniel Vater, Thomas Bast, René Santer, Erik-Jan Kamsteeg, Ron A Wevers, Friedrich Ebinger.   

Abstract

BACKGROUND: Typical cases of glucose transporter-1 deficiency syndrome (GLUT1-DS) present with early-onset epilepsy. We report symptoms, diagnostic results, and effects of therapy in two patients diagnosed with GLUT1-DS at the age of 10 and 15 years, respectively. PATIENTS: Patient 1: After four cerebral seizures in the first 2 years of life the patient was seizure-free but showed a complex movement disorder, expressive speech disorder, and mental retardation. Ratio of cerebrospinal fluid (CSF) to blood glucose was 0.41 (reference range 0.65 ± 0.1), molecular genetic testing confirmed GLUT1 deficiency with the novel pathogenic mutation c.1377dupC (p.Phe460LeufsX3) in the SLC2A1 gene. Following 9 months of ketogenic diet started at the age of 10 years, there was distinct improvement of speech and movement disorder. Patient 2 showed pharmacorefractive epilepsy, mental retardation, and a mild movement disorder. At the age of 15 years, extensive intake of food with high fat content was observed. Ratio of CSF to blood glucose was 0.41 (reference range 0.65 ± 0.1). The pathogenic mutation c.634C>T (p.Arg212Cys) was found in the SLC2A1 gene.
CONCLUSION: Self-induced high-fat diet can be a hint toward GLUT1-DS. Ketogenic diet can be beneficial even when started in late childhood, although it may take several months to achieve a positive effect. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622956     DOI: 10.1055/s-0032-1315433

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

1.  Dietary Treatments and New Therapeutic Perspective in GLUT1 Deficiency Syndrome.

Authors:  Pierangelo Veggiotti; Valentina De Giorgis
Journal:  Curr Treat Options Neurol       Date:  2014-05       Impact factor: 3.598

Review 2.  Hemiplegic Migraine in Glut1 Deficiency Syndrome and Paroxysmal Dyskinesia at Ketogenic Diet Induction: Case Report and Literature Review.

Authors:  Janina Gburek-Augustat; Anja Heinze; Rami Abou Jamra; Andreas Merkenschlager
Journal:  Mov Disord Clin Pract       Date:  2020-10-06

Review 3.  The metabolic basis of epilepsy.

Authors:  Jong M Rho; Detlev Boison
Journal:  Nat Rev Neurol       Date:  2022-03-31       Impact factor: 44.711

Review 4.  Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).

Authors:  Toni S Pearson; Cigdem Akman; Veronica J Hinton; Kristin Engelstad; Darryl C De Vivo
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

5.  Diagnostic Challenges Associated with GLUT1 Deficiency: Phenotypic Variabilities and Evolving Clinical Features.

Authors:  Hyuna Kim; Jin Sook Lee; Youngha Lee; Soo Yeon Kim; Byung Chan Lim; Ki Joong Kim; Murim Choi; Jong Hee Chae
Journal:  Yonsei Med J       Date:  2019-12       Impact factor: 2.759

6.  NGS-Based Diagnosis of Treatable Neurogenetic Disorders in Adults: Opportunities and Challenges.

Authors:  Jean-Marc Good; Isis Atallah; Mayte Castro Jimenez; David Benninger; Thierry Kuntzer; Andrea Superti-Furga; Christel Tran
Journal:  Genes (Basel)       Date:  2021-05-06       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.